FTC

Illumina Appeals FTC’s Ruling to Divest Grail
Illumina Appeals FTC’s Ruling to Divest Grail
Medical Devices and Diagnostics Industry
Illumina
FTC
Grail
M&A
Flag link:
FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention
FTC’s Challenge to Amgen-Horizon Merger Sparks Industry Attention
BioSpace
Amgen
Horizon Therapeutics
FTC
M&A
Flag link:
Amgen's Horizon buyout delayed again, pushing closure possibly to December
Amgen's Horizon buyout delayed again, pushing closure possibly to December
Fierce Pharma
Amgen
Horizon Therapeutics
FTC
M&A
Flag link:
FTC probes Abbott for allegedly colluding on bids for state contracts
FTC probes Abbott for allegedly colluding on bids for state contracts
Medical Marketing and Media
Abbott Labs
Nestle
Reckitt Benckiser
collusion
FTC
state contracts
Flag link:
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Flag link:
On heels of Amgen lawsuit, FTC broadens investigation of PBMs
On heels of Amgen lawsuit, FTC broadens investigation of PBMs
BioPharma Dive
FTC
PBMs
Ascent Health Services
Zinc Health Services
Flag link:
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
CNBC
Horizon Therapeutics
M&A
Amgen
FTC
Flag link:
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Flag link:
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Flag link:
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
BioSpace
Amgen
Horizon Therapeutics
M&A
FTC
Flag link:
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
Medical Marketing and Media
Amgen
Horizon Therapeutics
FTC
M&A
Flag link:
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Fierce Pharma
Pfizer
Seagen
M&A
antitrust
DOJ
FTC
Flag link:
The FTC put pharma giants on notice for deceptive marketing claims. But does it actually have the authority?
The FTC put pharma giants on notice for deceptive marketing claims. But does it actually have the authority?
Medical Marketing and Media
FTC
pharma marketing
deceptive marketing
JNJ
Pfizer
Flag link:
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned?
Fierce Pharma
M&A
antitrust
FTC
Sanofi
Provention Bio
Pfizer
Seagen
Flag link:
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail
CNBC
FTC
Illumina
Grail
competition
M&A
diagnostics
Flag link:
FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
Endpoints
FTC
Parkinson's Disease
Apokyn
Supernus Pharmaceuticals
Sage Chemical
patents
Flag link:
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
In Pfizer-Seagen review, FTC has chance to set new pharma precedent
BioPharma Dive
FTC
Pfizer
Seagen
M&A
antitrust
anticompetitive practices
Flag link:
US deal watchdog's bark could be worse than its bite
US deal watchdog's bark could be worse than its bite
EP Vantage
M&A
FTC
Flag link:
FTC's Non-Compete Law Could Propel Rise in Trade Secrets Lawsuits
FTC's Non-Compete Law Could Propel Rise in Trade Secrets Lawsuits
BioSpace
FTC
non-compete
trade secrets
legal
Flag link:
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Fierce Pharma
Elizabeth Warren
Senate
FTC
M&A
Amgen
Horizon Therapeutics
Indivior
Opiant Pharmaceuticals
Flag link:

Pages